Farm Comunitarios. 2023 Apr 14;15(2):41-44. doi: 10.33620/FC.2173-9218.(2023).12

Complexity of diagnosis and treatment of neuropathic pain

Martínez Escrivá G1, López-de-Coca Pérez T1, 2, Moreno Royo L1, 2
1. Chair DeCo MICOF-CEU UCH, Universidad Cardenal Herrera CEU, Valencia, Spain. 2. Pharmacy Department, Universidad Cardenal Herrera CEU, Valencia, Spain.
Martínez G, López-de-Coca T, Moreno L. Complexity of diagnosis and treatment of neuropathic pain. Farm Comunitarios. 2023 Apr 14;15(2):41-44. doi: 10.33620/FC.2173-9218.(2023).12
Abstract : 

Fifty-six years old woman who had neurological health problems for 5 years since she suffered a traffic accident. She was diagnosed with parkinsonism. She came to the community pharmacy for information on screening for cognitive impairment because she reported frequent forgetfulness.

A pharmacotherapeutic evaluation of the treatment was carried out following the Dader methodology and the anticholinergic load (AC) of the medication was studied. According to the anticholinergic scale, the patient presented an AC of 3.25, which can be related to the appearance of adverse effects such as cognitive alterations. As her pain was not controlled, she was brought back to the physician to try to achieve an effective treatment. A functional neurological disorder and major depressive disorder were confirmed. With the new medication, the AC decreased to 1.

The treatment of neuropathic pain is complex and accurate diagnosis is important for effective treatment. Although, symptomatology often leads to misdiagnosis and treatment with drugs that are not effective in solving the problem and can lead to adverse reactions as in this situation. In these patients, it is necessary to reevaluate the treatment and their cognitive status periodically.

Editor: © SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. 
Copyright© SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria. This article is available from url https://www.farmaceuticoscomunitarios.org/. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en

Share

-

Related contents

Manual for authors

Journal Information